The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

(2015) Steven Y. C. Tong et al.   CLINICAL MICROBIOLOGY REVIEWS

A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults

(2015) Michael Nissen et al.   VACCINE

USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the cap5 Locus

(2015) Susan Boyle-Vavra et al.   mBio

Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial

(2015) Jack Levy et al.   Human Vaccines & Immunotherapeutics

Efficacy profile of a bivalent Staphylococcus aureusglycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

(2015) Ali Fattom et al.   Human Vaccines & Immunotherapeutics

Update on the antibiotic resistance crisis

(2014) Gian Maria Rossolini et al.   CURRENT OPINION IN PHARMACOLOGY

Antibodies to Staphylococcus aureus Serotype 8 Capsular Polysaccharide React with and Protect against Serotype 5 and 8 Isolates

(2014) Saeyoung Park et al.   INFECTION AND IMMUNITY

Neutrophil-Mediated Phagocytosis of Staphylococcus aureus

(2014) Kok P. M. van Kessel et al.   Frontiers in Immunology

Protein Antigens Increase the Protective Efficacy of a Capsule-Based Vaccine against Staphylococcus aureus in a Rat Model of Osteomyelitis

(2013) Santiago M. Lattar et al.   INFECTION AND IMMUNITY

Community-associated MRSA: What makes them special?

(2013) Michael Otto   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery

(2013) Vance G. Fowler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Collagen-binding Microbial Surface Components Recognizing Adhesive Matrix Molecule (MSCRAMM) of Gram-positive Bacteria Inhibit Complement Activation via the Classical Pathway

(2013) Mingsong Kang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Staphylococcus aureus Formyl Peptide Receptor-like 1 Inhibitor (FLIPr) and Its Homologue FLIPr-like Are Potent Fc R Antagonists That Inhibit IgG-Mediated Effector Functions

(2013) A. M. Stemerding et al.   JOURNAL OF IMMUNOLOGY

Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli

(2013) Michael Wacker et al.   JOURNAL OF INFECTIOUS DISEASES

Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus

(2013) Timothy J. Foster et al.   NATURE REVIEWS MICROBIOLOGY

Phagocytosis Escape by a Staphylococcus aureus Protein That Connects Complement and Coagulation Proteins at the Bacterial Surface

(2013) Ya-Ping Ko et al.   PLoS Pathogens

Role of the Accessory Gene Regulatoragrin Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis

(2011) Gordon Y. C. Cheung et al.   INFECTION AND IMMUNITY

Binding of Efb fromStaphylococcus aureusto Fibrinogen Blocks Neutrophil Adherence

(2011) Ya-Ping Ko et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

agr-Dependent Interactions of Staphylococcus aureus USA300 with Human Polymorphonuclear Neutrophils

(2010) Yun Yun Pang et al.   Journal of Innate Immunity

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

The SaeR/S Gene Regulatory System Is Essential for Innate Immune Evasion byStaphylococcus aureus

(2009) Jovanka M. Voyich et al.   JOURNAL OF INFECTIOUS DISEASES

Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway

(2009) Saotomo Itoh et al.   MOLECULAR IMMUNOLOGY